A detailed history of Mascoma Wealth Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Mascoma Wealth Management LLC holds 67 shares of NVS stock, worth $7,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67
Previous 67 -0.0%
Holding current value
$7,131
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022

BUY
$80.11 - $90.62 $5,367 - $6,071
67 New
67 $6,000
Q1 2019

Apr 23, 2019

SELL
$75.32 - $86.15 $3,012 - $3,446
-40 Closed
0 $0
Q1 2018

Apr 24, 2018

SELL
$70.39 - $84.15 $4,223 - $5,049
-60 Reduced 60.0%
40 $3,000
Q4 2017

Feb 05, 2018

SELL
$72.33 - $77.64 $28,932 - $31,056
-400 Reduced 80.0%
100 $9,000
Q3 2017

Nov 07, 2017

BUY
$74.14 - $77.27 $37,070 - $38,635
500
500 $43,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $229B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mascoma Wealth Management LLC Portfolio

Follow Mascoma Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mascoma Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mascoma Wealth Management LLC with notifications on news.